BUTALBITAL, ACETAMINOPHEN AND CAFFEINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Butalbital, Acetaminophen And Caffeine, and when can generic versions of Butalbital, Acetaminophen And Caffeine launch?
Butalbital, Acetaminophen And Caffeine is a drug marketed by Aurolife Pharma Llc, Dr Reddys Labs Sa, Gilbert Labs, Graham Dm, Granules, Hikma, Lannett Co Inc, Lgm Pharma, Mallinckrodt, Novast Labs, Nuvo Pharms Inc, Quagen, Senores Pharms, Taro, Xspire Pharma, Mikart, Abhai Llc, Able, Actavis Labs Ut Inc, Alvogen, Hikma Pharms, Mirror Pharms Llc, Nesher Pharms, Specgx Llc, Strides Pharma, Sun Pharm Industries, Vintage Pharms, and Watson Labs. and is included in forty-five NDAs.
The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
Summary for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
| US Patents: | 0 |
| Applicants: | 28 |
| NDAs: | 45 |
| Finished Product Suppliers / Packagers: | 35 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Clinical Trials: | 1 |
| Patent Applications: | 47 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE at DailyMed |
Recent Clinical Trials for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| GlaxoSmithKline | Phase 3 |
See all BUTALBITAL, ACETAMINOPHEN AND CAFFEINE clinical trials
Pharmacology for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
| Drug Class | Barbiturate Central Nervous System Stimulant Methylxanthine |
| Physiological Effect | Central Nervous System Stimulation |
Anatomical Therapeutic Chemical (ATC) Classes for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
US Patents and Regulatory Information for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Specgx Llc | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | TABLET;ORAL | 087804-001 | Jan 24, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hikma | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | TABLET;ORAL | 040336-001 | Aug 18, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Vintage Pharms | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | TABLET;ORAL | 040513-001 | Aug 25, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
